Background
==========

The development of ovarian follicles leading to ovulation requires endocrine regulation by the gonadotropins FSH and LH as the main actors. The complex regulatory network also includes steroids and peptides (e.g. growth factors, inhibins) acting via the autocrine and paracrine pathways. Recent studies have highlighted the importance of FSH in ovarian follicle maturation: in FSH-deficient mice the folliculogenesis is blocked prior to antral formation \[[@B1],[@B2]\]. In order to obtain functional gametes, granulosa cell (GC) communication with the oocyte also seems essential \[[@B2],[@B3]\]. GCs constitute an important compartment in the mammalian ovarian follicle, contributing to follicle development. They actively participate in the endocrine function of the ovaries by secreting oestradiol or progesterone under FSH stimulation. Besides their functional importance, GCs have been intensively studied for their convenient isolation. In murine, porcine, and bovine species they constitute a well-standardized model for the *in vitro*study of GC function, including hormonal regulation.

Even if much data has been accumulated on the action of gonadotropins on GCs, the entire spectrum of genes regulated by FSH is not known. Besides recent advances in the generation of normalized cDNA libraries \[[@B4],[@B5]\] and expression analysis with differential display PCR and microarrays \[[@B6],[@B7]\], SSH approach \[[@B8]\] was more efficient in accessing low-level expressed transcripts. We have therefore used the SSH method to isolate FSH-regulated genes in pig primary GC. These results increase our understanding of the physiological processes involved in the response of GC to FSH. In particular, FSH may play a role in the modulation of peroxidase activities and the remodelling of chromatin.

Methods
=======

Cell cultures
-------------

Pig granulosa cells were isolated and cultured as described previously by Hatey *et al*\[[@B9]\]. Briefly, the granulosa cells were isolated from medium (around 3 mm in diameter) healthy follicles from immature swine ovaries. Cells were plated and grown to confluence in a serum-containing medium, which was replaced after 5 days of culture by a serum-free medium with or without FSH (Gonal-F™ 0.5 UI/ml, Serono laboratory) and incubated for a 48-h period before RNA extraction. FSH stimulation efficiency was tested both by measuring progesterone secretion in the culture medium using HPLC analysis \[[@B10]\] and by controlling the increase in P450scc and IGF1 genes expression using Northern blot analysis.

RNA and polyA extraction
------------------------

Total RNA extraction was performed according to Chomczynski and Sacchi \[[@B11]\] with minor modifications \[[@B12]\]. Poly(A)-containing RNA was selected with Dynabeads mRNA Purification Kit (Dynal) following the manufacturer\'s instructions. For quality control, total RNA and mRNA were denatured with formaldehyde and size-fractionated through a 1% agarose gel according to standard methods. The integrity of each RNA sample was checked by ethidium bromide staining of the gel. Before reverse transcription, DNase I treatment of RNA was performed as described \[[@B13]\].

Reverse-Transcription
---------------------

Total DNase I treated RNA (2 μg) from control and induced cells were used for reverse transcription (RT) using Superscript™ II Reverse Transcriptase (Invitrogen) and oligo-dT15 primers (Roche) according to the manufacturer\'s recommendations.

Suppression subtractive hybridization (SSH)
-------------------------------------------

SSH was performed with 1 μg of mRNA using the Clontech PCR-Select cDNA Subtraction Kit (Clontech) with minor modifications. The primary PCR amplification was achieved through 30 PCR cycles starting with 1 μl of 6 fold diluted second hybridization reaction. The secondary PCR amplification was achieved through 12 PCR cycles starting with 2 μl of 10 fold diluted primary PCR amplification. The PCR products were cloned using the TOPO™ TA Cloning^R^Kit (Invitrogen). Agarose gel analysis allowed the exclusion of empty clones or those containing more than one product. Forward subtraction H1 (FSH/C) used mRNA of control cells as a driver to select genes induced by FSH and reverse subtraction H2 (C/FSH) used mRNA of FSH-induced cells as a driver to select genes repressed by FSH.

Differential screening
----------------------

As the final SSH products were enriched, but not strictly composed of differentially expressed cDNAs, a screening procedure was set up to sort out the false positive clones. Inserts were amplified by PCR starting from each colony. Each cDNA was amplified by PCRusing Invitrogen Taq polymerase: initiation with one cycle of 7 min at 94°C and amplification with 20 cycles (94°C for 30 s, 68°C for 30 s and 72°C for 1.5 min). Primers used were nested PCR primer1 (5\'-TCGAGCGGCCGCCCGGGCAGGT-3\') and nested PCR primer2 (5\'-AGGGCGTGGTGCGGAGGGCGGT-3\'). PCR products were checked by electrophoresis on agarose gel. PCR products were denaturated in NaOH 0.5 M, EDTA 25 mM and 5% bromophenol blue, vacuum transferred onto two identical Hybond N membranes (Millipore) and UV crossed-linked. Macro-arrays were subsequently hybridized with the different probes (cDNA of control and treated cells). The screening was performed visually.

Probe labelling and hybridization
---------------------------------

Probe labelling with dCTP α ^32^P and hybridization of Northern-blot or macro-arrays were performed as described \[[@B9]\].

Sequencing reaction and analysis
--------------------------------

The inserts of regulated clones were amplified from the plasmid using Primer1 (5\'-GTAATACGACTCACTAGGGC-3\'), and Primer2 (5\'-TGTAGCGTGAAGACGACAGAA-3\'). PCR products were purified using Wizard^®^PCR Preps DNA Purification System (Promega). Sequencing was performed using the ABI PRISM™ Big Dye™ Terminator Cycle Sequencing Ready Reaction Kit (Applied Biosystems) and the Perkin-Elmer 377 apparatus (Perkin-Elmer Cetus). Sequences were submitted to EMBL database and accession numbers are given in Table [2](#T2){ref-type="table"}. Sequence assembling was done using the Wisconsin Genetic Computer Group software package (Wisconsin Package, version 10.0, Genetic Computer Group). Edited sequence data were analysed with the Advanced BLAST program of the EMBL web site for similarities with known genes or ESTs in the entire EMBL databases.

###### 

Identification of cDNA clones. The table gives the identification of the cDNA clones using blast analysis against EMBL/NCBI database. The clones were ranked by HUGO symbol (Human Genome Organisation). H1-clones correspond to forward hybridization (FSH-induced genes) and H2-clones to reverse hybridization (FSH-repressed genes).

  Clone    Matching Sequences                                                                                                                                                                               
  -------- ----------------------- ------------------ ------------------------------------------------------------------------------ --------- ------------ ------------------ ---------------------------- ---------
  clone    EMBL accession number   insert size (bp)   identification                                                                 species   Similarity   accession number   HUGO symbol                  
                                                                                                                                                                                                            
                                                                                                                                               \%           bp                                              
  H2-146   [AJ704910](AJ704910)    255                actin, alpha 2, smooth muscle, aorta                                           HS        96           211                [MN_001613](MN_001613)       ACTA2
  H2-96    [AJ704907](AJ704907)    111                actin, gamma 1                                                                 HS        89           119                [NM_001614](NM_001614)       ACTG1
  H1-2     [AJ704867](AJ704867)    186                cytosolic dihydrodiol dehydrogenase 3                                          BT        90           115                [D49542](D49542)             AKR1C3
  H2-222   [AJ704918](AJ704918)    643                annexin A5                                                                     HS        93           495                [CR541842](CR541842)         ANXA5
  H1-378   [AJ704899](AJ704899)    76                 ADP-ribosylation factor 1                                                      HS        91           74                 [AF493881](AF493881)         ARF1
  H1-98    [AJ704876](AJ704876)    166                mitochondrial ATPase 6                                                         SS        98           165                [AF250315](AF250315)         ATP6
  H1-138   [AJ704880](AJ704880)    354                calpain I light subunit                                                        SS        99           353                [M11778](M11778)             CAPNS1
  H1-357   [AJ704896](AJ704896)    107                Cctg for chaperonin                                                            HS        96           104                [X74801](X74801)             CCT3
  H1-124   [AJ704878](AJ704878)    177                Pig complement cytolysis inhibitor                                             SS        99           171                [M84639](M84639)             clu
  H1-61    [AJ704870](AJ704870)    245                alpha collagene human type IV(alport syndrome)                                 SS        82           162                [M31115](M31115)             col4A5
  H2-108   [AJ704909](AJ704909)    410                cytochrome c oxidase II                                                        SS        99           410                [U18827](U18827)             COXII
  H1-253   [AJ704887](AJ704887)    99                 chondroitin sulfate proteoglycan 6                                             HS        89           88                 [BC047324](BC047324)         CSPG6
  H1-280   [AJ704890](AJ704890)    251                cytochrome P-450 (SCC)                                                         SS        99           249                [X13768](X13768)             CYP11A1
  H1-365   [AJ704898](AJ704898)    110                7-dehydrocholesterol reductase (DHCR7)                                         HS        95           111                [AF062481](AF062481)         DHCR7
  H1-140   [AJ704881](AJ704881)    143                farnesyl diphosphate synthase                                                  BT        89           75                 [AF461050](AF461050)         FDPS
  H1-185   [AJ783757](AJ783757)    366                glutathione peroxidase 3 (plasma) (GPX3)                                       HS        87           354                [NM_002084](NM_002084)       GPX3
  H2-200   [AJ704914](AJ704914)    179                glycogenin                                                                     HS        83           179                [NM_004130](NM_004130)       GYG
  H2-105   [AJ704908](AJ704908)    228                Homo sapiens heterochromatin protein 1, binding protein 3                      HS        92           219                [BC045660](BC045660)         HP1BP3
  H1-1     [AJ704866](AJ704866)    256                3 β hydroxysteroidogenase                                                      SS        99           256                [AF232699](AF232699)         HSD3B1
  H2-265   [AJ704919](AJ704919)    299                inositol polyphosphate-1-phosphatase                                           HS        89           229                [NM_002194](NM_002194)       INPP1
  H2-175   [AJ704912](AJ704912)    187                matrin 3                                                                       HS        88           186                [NM_018834](NM_018834)       MATR3
  H1-100   [AJ704877](AJ704877)    237                NAC alpha                                                                      HS        92           237                [AY034001](AY034001)         NACA
  H1-242   [AJ704885](AJ704885)    481                complete mitochondrial DNA                                                     SS        100          450                [AJ002189](AJ002189)         NADH1
  H2-201   [AJ785755](AJ785755)    170                Sus scrofa breed Landrace mitochondrion                                        SS        100          170                [AF304202](AF304202)         NADH5
  H1-33    [AJ704869](AJ704869)    141                peroxiredoxin 2                                                                BT        86           117                [AF305562](AF305562)         PDX2
  H1-266   [AJ704888](AJ704888)    135                non-selenium glutathione phospholipid hydroperoxide peroxidase (phgpx gene)    SS        100          135                [AJ243849](AJ243849)         phgpx
  H2-29    [AJ704900](AJ704900)    123                proteasome (prosome, macropain) 26S subunit, ATPase                            HS        86           123                [NM_002806](NM_002806)       PSMC6
  H1-358   [AJ704897](AJ704897)    87                 cDNA DKFZp686F06244                                                            HS        97           87                 [HSM806676](HSM806676)       Q8NEW0
  H1-73    [AJ704872](AJ704872)    120                ribosomal protein S15A                                                         HS        93           130                [BC001697](BC001697)         RPS15A
  H1-129   [AJ704879](AJ704879)    467                Sterol regulatory element binding protein cleavage-activating protein (SCAP)   SS        88           486                [AY705447](AY705447)         SCAP
  H1-90    [AJ704873](AJ704873)    199                high density lipoprotein receptor SR-BI mRNA                                   SS        99           199                [AF467889](AF467889)         SCARB1
  H1-96    [AJ704875](AJ704875)    404                splicing factor 3a, subunit 3                                                  HS        93           401                [NM_006802](NM_006802)       SF3A3
  H1-62    [AJ704871](AJ704871)    90                 solute carrier family 25                                                       HS        85           98                 [BC008737](BC008737)         SLC25A6
  H2-44    [AJ704902](AJ704902)    529                thrombospondin 1                                                               BT        90           527                [AB005287](AB005287)         THBS1
  H1-94    [AJ704874](AJ704874)    114                tenascin                                                                       HS        91           114                [D49542.1](D49542.1)         TNC
  H2-72    [AJ704904](AJ704904)    133                ubiquitin associated protein 2 (UBAP2), transcript variant 1                   HS        91           106                [NM_018449.2](NM_018449.2)   UBAP2
  H1-202   [AJ704883](AJ704883)    178                ubiquitin-conjugating enzyme E2E 2                                             HS        98           178                [BC022332](BC022332)         UBE2E2
  H1-305   [AJ704893](AJ704893)    178                angiogenic factor VG5Q,                                                        HS        85           169                [BC032844](BC032844)         VG5Q
  H2-37    [AJ704901](AJ704901)    451                vimentin                                                                       HS        92           438                [NM_003380](NM_003380)       VIM
  H2-170   [AJ704911](AJ704911)    191                breed Landrace mitochondrion                                                   SS        100          190                [AF304202](AF304202)         unknown
  H2-202   [AJ704915](AJ704915)    120                domestica mitochondrial D-loop,                                                SS        100          120                [AF276937](AF276937)         unknown
  H1-180   [AJ704882](AJ704882)    178                885998 MARC 4PIG                                                               SS        99           178                [CF792994](CF792994)         unknown
  H1-246   [AJ704886](AJ704886)    284                jns82_C06.f jns 5\'                                                            SS        99           284                [CB481752](CB481752)         unknown
  H1-276   [AJ704889](AJ704889)    247                MI-P-CP0-nvm-c-03-0-UI.s2 MI-P-CP0                                             SS        99           236                [BQ603741](BQ603741)         unknown
  H1-294   [AJ704891](AJ704891)    131                855499 MARC 4PIG 5\'                                                           SS        98           118                [CF787582](CF787582)         unknown
  H1-345   [AJ704895](AJ704895)    90                 820907 MARC 3PIG 3\'                                                           SS        10           89                 [CF359642](CF359642)         unknown
  H2-92    [AJ704905](AJ704905)    497                jns96_H04.f jns                                                                SS        99           492                [CB482726](CB482726)         unknown
  H2-199   [AJ704913](AJ704913)    236                903820 MARC 4PIG 3\'                                                           SS        99           236                [CK450726](CK450726)         unknown
  H1-338   [AJ704894](AJ704894)    97                 , Similar to RIKEN cDNA 2410141M05 gene                                        HS        91           92                 [BC008630](BC008630)         unknown
  H2-216   [AJ704917](AJ704917)    107                RIKEN full-length enriched library, product: ribosomal protein S17             MM        94           93                 [AK007992](AK007992)         unknown
  H2-288   [AJ704920](AJ704920)    162                CT02029A1F04 Equine Articular Cartilage                                        EC        87           114                [CX601260](CX601260)         unknown
  H1-14    [AJ704868](AJ704868)    221                endogenous retrovirus PERV-MSL                                                 SS        97           221                [AF038600](AF038600)         
  H1-302   [AJ704892](AJ704892)    108                None                                                                           SS                                                                     
  H2-95    [AJ704906](AJ704906)    137                None                                                                           SS                                                                     
  H2-206   [AJ704916](AJ704916)    658                None                                                                           SS                                                                     

Comparative RT-PCR analysis
---------------------------

The comparative RT-PCR was performed as described by Tosser-Klopp *et al*\[[@B13]\]. Briefly, 0.5 μCi of α ^32^P labelled dCTP (specific activity \>3000 Ci.mmole^-1^, Perkin Elmer) was added to each reverse transcription to monitor the transcription. First strand cDNAs were purified by G50 chromatography and quantified by measuring the incorporated radioactivity. For each cDNA sample (control and FSH-treated cells) the same dilutions were made starting from the same amount of material. The PCR conditions were: denaturation 5 min at 94°C, followed by (22--40) cycles of (30 s, 94°C, 30 s, 56°C, 1.5 min, 72°C) in presence of 1.5 mM MgCl~2~. The primers are listed in table [4](#T4){ref-type="table"}. Ten μl of PCR products were analysed by electrophoresis on 1.5% agarose gel. Each experiment was performed at least three times. An external standard (plant mRNA: I11a accession number: y10291) was added to each RNA sample (200 fg for 2 μg total RNA sample) before reverse transcription and allowed the control of the cDNAs quantifications and dilutions using specific primers (Figure [1](#F1){ref-type="fig"}).

###### 

Localisation on pig chromosomes. This table gives the localisation obtained using SCHP and/or ImpRH panel hybrid. The result of SCHP consists in the chromosomal region with statistical scores: error risk and probability. For IMpRH the results were obtained by 2-point analysis. We indicate the number of hybrid clones used (90 or 118 Hybrids), the retention as a % frequency (% ret), the bearing chromosome, the closest marker, the location in Ray, and the load score value. We have indicated the chromosomal localisation in humans when known; the expected localisation in pigs derives from comparative mapping between humans and pigs.

  Clone    Putative identification   Somatic localisation   IMpRH panel used   IMpRH localisation using two point analysis   Human localisation   pig expected localisation                                                                           
  -------- ------------------------- ---------------------- ------------------ --------------------------------------------- -------------------- --------------------------- ----- -------------------------------- ---------- ------- ------------- ----
                                     *Location*             *% Error risk*     *Prob.*                                                            \% ret                      Chr   Name of the most linked marker   Location   LOD                   
                                                                                                                                                                                                                                                      
  H1-2     AKR1C3                                                                                                            90                   34                          14    EST-AR023C05                     4.74       4.81    10p 15 p 14   10
  H1-61    col4A5                    X p 24                 0.10               0.77                                          90                   50                          X     SW1426                           7.1        14.32   X q22         X
  H1-129   SCAP                                                                                                              90                   25                          13    EST-AR062F01                     11.44      19.28   3 p 21.31     13
  H1-140   FDPS                      4 p14-p15              0.10               1.00                                          90                   24                          4     IMpRH01700                       26.17      15.94   1 q 22        4
  H1-180   EST                       9 p21-p24              5                  0.63                                          118                  35                          9     SW911                            3.83       10.89                 
  H1-246   EST                       9 p21-p24              5                  0.63                                          118                  40                          9     SW911                            3.83       14.49                 
  H1-276   EST                       10 p1-p16              0.10               0.80                                          118                  29                          2     PTH3                             10.97      5.05                  
  H2-44    THBS1                     1 p24-p25              1                  0.81                                          118                  29                          1     348A10F                          27.08      5.95    15 q 15       1
  H2-92    EST                       14?                    0.50               1.00                                          90                   31                          14    RhC21D6F                         19.69      15.71                 
  H2-95    EST                       4 p14-p15              1                  0.76                                          118                  35                          4     S0107                            18.07      12.08                 

![**validation of comparative RT-PCR**. Comparison ofNorthern and RT-PCR analysis with H1-180 and H1-129. A shows Northern analysis of total RNA (5 μg) from control (C) or FSH-treated GCs (FSH). Hybridization was performed with H1-180 and H1-129 cDNA probes coming from forward hybridization (H1 = FSH-induced genes). The amount and integrity of RNA in each lane was checked with ethidium bromide staining of the gels before transfer (28 S lane). B shows the results of PCR amplification of H1-180 and H1-129 cDNAs using specific primers. Total RNA was extracted from control (C) or FSH-treated (FSH) cells and was reverse-transcribed. For PCR, four different amounts of each cDNA were used: **a:**1 ng, **b:**250 pg, **c:**50 pg, **d:**10 pg and 2 controls (-: water, **+**: corresponding insert). PCR amplification of I11a (plant external control added to each RNA before RT) was performed on the same samples (control and FSH-treated cDNAs) to check efficiency of the RT and PCR processes.](1477-7827-4-35-1){#F1}

Regional assignment
-------------------

Genomic localisation of the PCR products was done using the pig somatic cell hybrid panel (SCHP) as described previously by Tosser-Klopp *et al*. \[[@B13]\]. Each hybrid was scored for the presence of a pig specific DNA fragment and the assignments were performed using online software \[[@B14]\].

We also used the IMpRH panel 7000 rads \[[@B15]\] as described by Lahbib-Mansais *et al*.\[[@B16]\]. The results of radiation hybrid PCR products were analysed using the IMpRH mapping tool \[[@B17],[@B18]\].

Functional Gene Ontology annotation
-----------------------------------

The functional annotation analysis was performed on the 25 genes found to be regulated by Northern or comparative RT-PCR.

Since our sequences are rather short, and mainly belong to 3\'UTR portions of genes, available public tools to assign GO molecular function to nucleic acid sequences lack sensitivity. So we set up the following workflow:

\- Each sequence was compared to EMBL database via a NCBI blastn with an e-value limit set to 1e-3

\- Blast results were parsed and filtered to keep hits having a) at least a coverage of 50% of the query sequence, b) 70% of identities, c) its coordinates inside a gene/mRNA/CDS location on the subject sequence.

\- For each query sequence, candidate hits were sorted by a) their closeness to the pig genome, and b) their coverage and percent of identity.

\- Annotations present in the EMBL record of the hit were parsed to look for cross references to proteins from UniProt/SwissProt databases

\- Finally, using cross reference tables provided by GOA <http://www.ebi.ac.uk/GOA/>, molecular function GO was inferred from these best hits and associated to the sequences.

Results
=======

Suppression subtractive hybridization
-------------------------------------

The SSH approach was performed on primary granulosa cells from cultures treated or not treated by FSH. mRNA from control granulosa cells was subtracted from the mRNA from FSH treated granulosa cells and *vice versa*. We isolated 226 clones from the forward hybridization H1 (FSH/C, FSH-induced genes) and 275 from the reverse subtraction H2 (C/FSH, FSH-repressed genes). In order to eliminate false positive clones, differential screening was used. The clones were spotted on two sets of macro-arrays and differential screening was performed using cDNA from the control and the treated cells as probes. We identified 28 (12.4%) induced cDNA clones and 19 (6.9%) repressed cDNA clones (Table [1](#T1){ref-type="table"}). We also randomly selected 29 cDNA clones in both forward and reverse subtraction which provided no differential signals or no signal at all.

###### 

Differential screening by macro-arrays. This table summarises the results of differential screening by SSH and the results of sequence analysis: Forward subtraction corresponds to H1 SSH and up-regulated genes by FSH (FSH/C). Reverse one corresponds to H2 SSH and down-regulated genes by FSH (C/FSH). Random selection corresponds to clones that provided no differential signals or no signal at all in both forward and reverse subtraction.

                                              Forward (FSH/C)   reverse (C/FSH)   random selection   total
  ------------------------------------------- ----------------- ----------------- ------------------ -------
  number of clones                            226               275                                  501
  number of selected clones after screening   28 (12.4%)        19 (6.9%)         29                 76
  different clones                            20                15                29                 64
  different genes                             18                12                27                 55

Sequence analysis
-----------------

These 76 selected clones (28+19+29) were sequenced and compared against public sequence databases. We identified 64 different sequences of which 3 were novel and 14 corresponded to different regions of the same 5 genes. We finally dealt with 55 genes. The results are summarized in Table [1](#T1){ref-type="table"}. The complete list of genes is given in Table [2](#T2){ref-type="table"}.

Regulation study
----------------

Northern and comparative RT-PCR were used to analyse the differential expression of the selected genes. Out of the 55 genes, 18 could not be analysed according to their short length.

The results of the 37 genes left are presented in Table [3](#T3){ref-type="table"}. Some genes could not be analysed by Northern (no signal or non interpretable results) and were thus analysed by RT-PCR. Also, 9 genes which gave a good signal by Northern analysis were also analysed by RT-PCR to compare the results (Fig [1](#F1){ref-type="fig"}).

###### 

RNA expression. Results of RNA expression for the 37 genes. Nine genes are analysed by both Northern and comparative RT-PCR. For comparative RT-PCR the regulation was determined using cDNA dilutions from control cells and FSH treated cells as in Figure 1 and 2. In the Table, C = FSH corresponds to non regulated genes by FSH, FSH\>C corresponds to up-regulated genes and C\>FSH corresponds to down-regulated genes. NI corresponds to Non Interpretable, 0 corresponds to no signal. \* these genes gave no signals during macro-array screening and thus were not controlled by Northern.

  -----------------------------------------------------------------------------------------------------------------------------------------
  clones   putative identification                  Northern   RT-PCR result   primers                           Size of PCR product (pb)
  -------- ---------------------------------------- ---------- --------------- --------------------------------- --------------------------
  H2-146   ACTA2                                    C\>FSH                                                       

  H2-96    ACTG1                                    C\>FSH                                                       

  H1-2     AKR1C3                                   FSH\>C                     U: GATCATCTCCAGCTGCTTGT\          123
                                                                               L: AGGAGCTTCTGCCTAAGGAT           

  H2-222   ANXA5                                    C\>FSH                                                       

  H1-98    ATP6                                     NI         C = FSH         U: TACGGCTAGGGCTACTGG\            126
                                                                               L: TTCCGCCATAAAACCAAAAC           

  H1-138   CAPNS1                                   C = FSH    C = FSH         U: ACGGGGTGAGTCTAATGC\            348
                                                                               L: CCAGTGAAGTGCCCAGAA             

  H1-357   CCT3                                     FSH\>C                                                       

  H1-124   CLU                                      C = FSH    C = FSH         U: ACCCCAGCGTG CCTCT\             122
                                                                               L: TTCCTCCGCCACAGTCTC             

  H1-61    Col4A5                                   FSH\>C     FSH\>C          U: CATAAAAAGCACAGGGAAAAG\         172
                                                                               L: TTTCTCTTCTGCTGTATTCG           

  H2-108   COX II                                   FSH\>C                                                       

  H1-280   CYP11A1                                  NI         FSH\>C          U: CAAGTCATTCACGAGGTATC\          161
                                                                               L: AGGAGATGCTGCGGGAG              

  H1-185   GPX3                                     FSH\>C                                                       

  H2-105   HP1BP3                                   \*         FSH\>C          U: CTCAAGTCCATTTCCCAGC\           114
                                                                               L: TCTGGCTCCTTGCGTGCT             

  H1-1     HSD3B1                                   FSH\>C                                                       

  H2-265   INPP1                                    C\>FSH                                                       

  H2-175   MATR3                                    \*         C\>FSH          U: GTTTTTGTTTTATCAGAATGG\         91
                                                                               L: CTTATCTTTCTTAGTGGTGC           

  H1-100   NACA                                     C = FSH    C = FSH         U: AAG AGG AGA GTG AAG AGG A\     197
                                                                               L: TTGAAACACCAAAAAAAGGGT          

  H1-242   NADH1                                    0          C = FSH         U: TTGGTGAATAGTTTTAGGGC\          360
                                                                               L: CGAAAGGACAAGAGAAATGG           

  H1-33    PDX2                                     NI         C = FSH         U: TGACCCAGGAAAGCCAGA\            129
                                                                               L: CTATGTCGCTCCAGGAAA             

  H1-14    porcine endogenous retrovirus perv-MSL   0          FSH\>C          U: AAAACAGCAAAAAACCTAACC\         180
                                                                               L: GCCCGTCTAACAAGAAAGC            

  H1-73    RP515A                                   C = FSH                                                      

  H1-129   SCAP                                     FSH\>C     FSH\>C          U: CCAGCCCAGATCCAGTG\             250
                                                                               L: TAAACTACGGGGACCTGT             

  H1-90    SCARB1                                   NI         FSH\>C          U: CAAGAAGCAAGACTGTAGG\           160
                                                                               L: TGGCAACGGGAGGTGAG              

  H1-62    SLC25A6                                  NI         C = FSH         U: GTTCTCTTTTGCACAGCCG\           86
                                                                               L: TTTTTTTGTGTCCTGATTTTATT        

  H2-44    THBS1                                    C\>FSH                     U: CTTTTCGTCTCCCTGGAAAT\          529
                                                                               L: TGAAACTGATGGGCAAATCT           

  H1-94    TNC                                      0          C\>FSH          U: GCTCCGTGGTGGACCTG\             104
                                                                               L: CCCTCCACCTTCAGCTTG             

  H1-305   VG5Q                                     0          C = FSH         U: CCAGCATAAGCATCATTTTC\          174
                                                                               L: AACAGAGAACCACCCTCCT            

  H2-37    VIM                                      0          C = FSH         U: GCTCAAGGGGACCAACGA\            253
                                                                               L: TGGAAGAGGCAGAGAAATC            

  H2-95    New                                      0          C\>FSH          U: AGTCACCAATCTTATCTCCA\          119
                                                                               L: ATGAAACAATAGTCCAGGAAG          

  H1-202   unknown                                  C = FSH    C = FSH         U: ATCCTCAGTCAAAAGTGGCA\          154
                                                                               L: CAATCAGAATCACTGTGCGT           

  H2-288   unknown                                  \*         C = FSH         U: AAGGTGTGTTGATGTATTTTA\         77
                                                                               L: TACAGGAAGGGAAGCATC             

  H1-294   unknown                                  FSH\>C     FSH\>C          U: CTTAGTTTCAGACTGGAGTT\          104
                                                                               L: TTTAGCGGCTTGTTCACTCA           

  H2-92    unknown                                  \*         FSH\>C          U: ATGCCAACATCATCACCTCT\          351
                                                                               L: CCCTCTAAACTGGGATCCAT           

  H2-170   unknown                                  FSH\>C     FSH\>C          U: AGACTTGTAGGTAGAGGTGA\          99
                                                                               L: TAGGGTTTTTGGGGTATTTTT          

  H1-180   unknown                                  FSH\>C     FSH\>C          U: AAA TTG TAG GTA TAT GTG TCA\   123
                                                                               L: TAGAGAATAAAATGGTCAGTAA         

  H1-246   unknown                                  FSH\>C                     U: CAATTCACCATCATCCACAA\          284
                                                                               L: CCCAGCATTTCATACTGACC           

  H1-276   unknown                                  FSH\>C                     U: ACGATTCCTCTACTGAAAGCTG\        247
                                                                               L: TGTTTTTGGCAAACAGCAG            
  -----------------------------------------------------------------------------------------------------------------------------------------

Finally, out of the 37 genes, 25 were FSH-regulated (Table [3](#T3){ref-type="table"}). In agreement with literature, *HSD3B1*and *CYP11A*expression was induced by FSH in granulosa cells and *ACTA2*expression was repressed by FSH (Fig [2](#F2){ref-type="fig"}).

![**Regulation studies**. Regulation by FSH of 6 genesusing Northern or comparative RT-PCR. H1 corresponds to forward hybridization (FSH-induced genes) and H2 to reverse hybridization (FSH-repressed genes). A: Northern analysis. B: comparative RT-PCR. Same conditions as in Figure 1.](1477-7827-4-35-2){#F2}

FSH regulation of the expression of some other genes (*AKR1C3*, *col4A5*, *TNC*) is illustrated in Fig [2](#F2){ref-type="fig"}.

Chromosomal localisation
------------------------

Among the same 37 genes, 11 had already been located on pig chromosomes. Using the SCHP and the IMpRH hybrid panel, and the same primer pairs as for regulation studies, we tried to localise the 26 genes left. We successfully localised 10 genes, for the other 16 genes, the primers used amplified rodent DNA and stopped the analysis of the results (Table [4](#T4){ref-type="table"}).

Functional gene ontology analysis
---------------------------------

The 25 regulated genes were analysed using gene ontology annotation in order to document the processes involved in FSH effect on granulosa cells from medium sized follicles.

For each sequence, we tried to assign molecular function GO identifiers using the methodology explained previously. We limited the analysis to the first levels of the molecular function ontology tree, just counting genes present in each node. The donut chart of figure [3](#F3){ref-type="fig"} shows the distribution of the regulated genes according to their molecular function (see Additional file: supplementaldata-fig [3](#F3){ref-type="fig"} for the data used to draw the chart). As genes can be assigned to more than one molecular function, some categories are drawn as outer partial rings in the donut chart (see also supplemental data). Numbers in this chart represent the number of genes observed for each category.

![**Functional annotation: Molecular function**. The donut chart shows the distribution of the 25 regulated genes according to their molecular function (inner circle). Genes that can be assigned to more than one molecular function are indicated by outer partial rings in the donut chart. Numbers in this chart represent the number of sequences for each category.](1477-7827-4-35-3){#F3}

Discussion
==========

Our objective has been to identify the genes regulated in granulosa cells in response to FSH stimulation. The identification of such genes will give valuable information about the molecular processes associated with follicular growth. An increasing number of studies are being undertaken on candidate genes that regulate folliculogenesis, e.g. IGF \[[@B18]\], EGF \[[@B19]\], TGF-β \[[@B20]\] and other members of the transforming growth factor superfamily, like BMPs \[[@B21],[@B22]\] and GDF-9 \[[@B23],[@B24]\]. In parallel with such individual studies, we now have access to technologies that allow us to study a large number of genes simultaneously. We applied the SSH technique coupled with a differential screening procedure, to GCs treated with FSH compared with untreated controls. Among 501 clones initially obtained, 76 were sequenced and were found to correspond to 55 different genes (Table [2](#T2){ref-type="table"}). Sequence analysis revealed redundancy from 2 different mechanisms: 1) gene redundancy, and 2) clone redundancy. This phenomenon is observed for highly expressed genes like- *HSD3B1*and *alpha-actin*. High level of expression can also explain why two genes (*alpha-actin*and *complement cytosolic inhibitor*) are present in both the forward and reverse libraries (data not shown): the subtraction process may not be efficient for them.

Regulation studies
------------------

Thirty seven genes were analysed for regulation. Ten genes did not give a signal with Northern blot or macroarrays (table [3](#T3){ref-type="table"}) and were successfully analysed by RT-PCR, underlining the low level of expression of some genes identified through SSH: they probably correspond to rare transcripts.

*The Cox2*gene and H2-170 gave discordant results when using subtraction or Northern analysis, possibly due to the high abundance of their mRNAs \[[@B25],[@B26]\]. However, Northern experiments demonstrated clearly their high expression and regulation in granulosa cells.

We found some genes already known to be regulated by FSH in pigs e.g. *HSD3B*and *CYP11A*which are upregulated by FSH (Figure [2](#F2){ref-type="fig"}). We corroborated in pigs that *alpha*and *gamma actin*were downregulated by FSH, whereas *vimentin*was not affected, as observed in rats \[[@B27]\]. These genes validate the biological model and the analytical methods, as well as reinforcing previous studies \[[@B28]\].

Localisation of cDNA and comparative mapping
--------------------------------------------

This paper describes 10 localisations of genes or ESTs on the pig genome using the somatic or IMpRH hybrid panel. Three genes and 4 ESTs were assigned with a LOD score of \>10. Localisations of these genes were in accordance with the data from the human genome. In spite of a relatively low LOD score of 5.95 (significance limit 6), *THBS1*was assigned on chromosome 1 in agreement with the expected localisation, using a comparative map between humans and pigs \[[@B29],[@B30]\].

The aim of these localisations was to identify candidate genes for reproductive Quantitative Trait Loci (QTL). This could be the case for col4A5 which is located on chromosome X at the same place as a plasma FSH concentration QTL \[[@B31]\]. Col4A5 was up regulated by FSH and is a positional candidate for this QTL. This result obviously deserves further investigation.

Functional gene ontology analysis
---------------------------------

In order to understand the pathways involved in the GC response to FSH, GO was used to cluster regulated genes according to their molecular function. Most of the tools used for automatic GO annotation of EST sequences, such as GOst \[[@B32]\] or OntoBlast \[[@B33]\], are mainly based on homology searches against well annotated protein databases. In our case, the sequence information obtained from the SSH clones is relatively short, and is biased towards 3\' UTR; thus these tools are not convenient. Some other tools, such as Goblet \[[@B34]\], GoFigure \[[@B35]\] or Blast2GO \[[@B36]\] allow homology searches against nucleic databases, but once again with low sensitivity for short sequences. We thus used an in-house procedure to browse the GO classification and extract valuable information. The resulting classification (Fig [3](#F3){ref-type="fig"} and Additional file) brings to light mainly 5 functional activities: \"catalytic\" and \"signal transducer\" activities directly linked with the steroid activity then \"binding\", \"antioxidant\" and \"structural molecule\" activities predominantly linked with differentiation pathways. On the other hand, our data demonstrate for the first time the involvement and/or the regulation of different genes in:

### Catalytic activities

*COX-2*was upregulated by FSH in our study and has been implicated as an important factor in female fertility \[[@B37]\]. In response to FSH, *COX-2*induction could then stimulate progesterone production via the PGE2/EP2 pathway and play a role in ovulation by supporting cumulus expansion \[[@B38],[@B39]\]. Indeed, mice deficient for *COX-2*failed to ovulate, showing that *COX-2*is necessary for ovulation \[[@B40]\].

### Binding activity

Our data underline the FSH regulation of 4 genes involved in 1) DNA binding (*HP1-BP74*) 2) nucleic acid binding (*CCT3*), 3) lipid binding (*annexin V*), and 4) metal ion binding (*matrin*).

1\) The upregulation of the *HP1-BP74*gene (histone h1/h5 family), has never been shown before to be involved in granulosa cells development. Histones are highly conserved proteins involved in the package of chromosomes by interacting with DNA. Particularly, the HP1 family plays an important role in chromosomal biology and gene silencing. The *HP1-BP74*gene was also shown to be involved in neuronal functional maturation \[[@B41]\]. This finding suggests an important role of H2-105 in GC differerentiation.

2\) This study shows also the FSH up regulation of the *CCT3*gene (*chaperonin containing TCP1*) known to mediate the folding of alpha- and beta-tubulin. FSH could thus intensify the remodelling of the microtubule cytoskeleton. Such a modification has been shown to be related to the maintenance and remodelling of heterochromatin during mammalian spermiogenesis \[[@B42]\].

3\) We demonstrated the downregulation of *annexin V*: its binding to the cell membrane corresponds to the earlier events of apoptosis and is used to detect healthy live cells (annexin V negative) \[[@B43],[@B44]\]. It is also a protein kinase C inhibitor which plays a potential role in cellular signal transduction \[[@B45]\]. This downregulation by FSH in GC may prevent apoptosis.

4\) Finally, we found the downregulation of *matrin*by FSH. This protein that is localized in the nuclear matrix may have a role in RNA transcription thanks to its acidic region \[[@B46]\] and could be phosphorylated by nuclear PKC epsilon \[[@B47]\].

### Signal transducer activity

Among the genes involved in signal transducer activity, our study showed the upregulation by FSH of the *Scavenger Receptor Class B Type I (SCARB1)*. This receptor is involved in both cholesterol delivery for steroid hormone production and in the recognition of apoptotic granulosa cells. We underline here the relationship with steroid hormone production, according to the downregulation of *annexin V*by FSH that suggests a differentiation process rather than an atretic one \[[@B48]\].

### Anti-oxidant activities

During follicle growth, swine granulosa cells are physiologically exposed to a progressive oxygen shortage. In vitro reactive oxygen species (ROS), such as hydrogen peroxide (H2O2) and lipid hydroperoxide (LOOHs) provided by oxido-reduction reactions, can either negatively or positively affect the differentiation of the gametes notably during spermatogenesis \[[@B49],[@B50]\]. Among the anti-oxidant activities, we noticed the upregulation by FSH of genes like glutathione peroxydase 3 (*GPX3*). *GPX3*seems to regulate free hydoxyperoxides. The upregulation of this peroxidase activity by FSH could prevent atresia by protecting the membrane lipids and allowing differentiation of the follicle.

### Structural molecule activity

We identified several interesting regulated genes in the structural molecule activity because they intervene in the extracellular matrix and cytoskeleton. Adhesion proteins, such as type IV collagen, increase the connections between cells and have also been shown to increase FSH receptors and progesterone production of GCs from immature porcine ovarian follicles \[[@B51]\]. The stimulation by FSH of *type IV collagen*gene expression could thus reinforce the effect of FSH and play a role in the local control of ovarian follicular dynamics \[[@B52]\].

Conclusion
==========

These results demonstrate the validity of both our cellular model and the SSH approach in identifying genes involved in response to FSH. In this way, and in addition to the regulation of the steroidogenesis and morphological changes already described, our data suggests that there is a role of FSH in the chromatin remodelling and protection against peroxides leading the follicle into a differentiation process rather than into atresia. Interestingly, we have been able to demonstrate the involvement and/or regulation of new genes such as *HP1-BP74*, *cox-2*, *CCT3, SCARB1*, *GPX3*, and also of unidentified genes. These new or unidentified genes will require further studies. Particularly, expression studies associated with histological techniques (*in situ*hybridization, immunohistochemistry) will allow a better understanding of the involvement of these genes.

SSH has demonstrated its efficiency in our hands. We will now use it to further improve our knowledge of folliculogenesis in pigs by analysing fresh GC from ovarian follicles at different developmental stages.
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